• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Fibronectin type III domain-containing protein 3B (FNDC3B), Truncated

ACP01644

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP01644 Target NameFNDC3B
Target Synonyms(Factor for adipocyte differentiation 104)(HCV NS5A-binding protein 37)FormLiquid or Lyophilized powder
Expression SystemYeastExpression Range278-570aa
Mol Weight34.1 kDaProtein LengthPartial
PurityGreater than 90% as determined by SDS-PAGE.Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ53EP0
Background Information
  • Uniprot Id

    Q53EP0

  • Target Species

    Human

  • Target Name

    FNDC3B

  • Target Full Name

    Fibronectin type III domain-containing protein 3B

  • Target Function

    May be a positive regulator of adipogenesis.

  • Target Subcellular Location

    Membrane; Single-pass membrane protein.

  • Target Protein Families

    FNDC3 family

  • Target Tissue Specificity

    Predominantly expressed in white adipose tissue (WAT) especially in the stromal vascular cells. Expressed in adipocyte differentiable 3T3-L1 cells but not in the non-adipogenic cell line NIH-3T3. Expression increased in the early stage of adipogenesis.

  • Target Research Area

    Signal Transduction

  • Target Synonyms

    FNDC3B; FAD104; NS5ABP37; UNQ2421/PRO4979/PRO34274Fibronectin type III domain-containing protein 3B; Factor for adipocyte differentiation 104; HCV NS5A-binding protein 37

Inquire Recombinant Human Fibronectin type III domain-containing protein 3B (FNDC3B), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification